Feb 19, 2020 / 07:00PM GMT
Unidentified Analyst -
Hi, if you could take your seats, please. Please join me in welcoming Altria back to CAGNY and thanking them for sponsoring the break, which will take place immediately after this presentation.
Clearly, the tobacco industry has been going through significant change over the last couple of years with Altria navigating regulatory changes and consumer shifts through alternative products. Altria is addressing these changes by taking a portfolio approach with traditional products complemented by multiple potentially reduced-risk products, which include the commercial rights to IQOS in the U.S., its investment in JUUL and on!.
2019 was a tale of 2 cities with strong operating profit growth of 9% in its core smokeable segment, while JUUL faced a more difficult year. Altria has a market-leading smokeless franchise and is well positioned in heat-not-burn with IQOS, which is the first product to have received authorization by the FDA to launch a heat-not-burn product in the U.S. under the premarket tobacco application.
2020 will clearly be a year where Altria continues its
Altria Group Inc at Consumer Analyst Group of New York Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers